On 2025-05-14, ARS Pharmaceuticals, Inc. (SPRY) announced earnings per share of $-0.35 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.35.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.42 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.35 | $-0.35 |
| 2025-03-20 | 2024-12-31 | $-0.04 | $0.52 |
| 2024-11-13 | 2024-09-30 | $-0.18 | $-0.20 |
| 2024-08-06 | 2024-06-30 | $-0.12 | $-0.13 |
| 2024-05-09 | 2024-03-31 | $-0.11 | $-0.11 |
| 2024-03-21 | 2023-12-31 | $-0.14 | $-0.07 |
| 2023-11-09 | 2023-09-30 | $-0.18 | $-0.16 |
| 2023-08-10 | 2023-06-30 | $-0.17 | $-0.18 |
| 2023-05-15 | 2023-03-31 | $-0.17 | $-0.16 |
| 2022-11-02 | 2022-09-30 | -- | $-0.50 |
| 2022-08-11 | 2022-06-30 | $-0.62 | $-0.55 |
| 2022-05-12 | 2022-03-31 | $-0.67 | $-0.70 |
| 2022-03-31 | 2021-12-31 | $-0.70 | $-0.67 |
| 2021-11-10 | 2021-09-30 | $-0.72 | $-0.65 |
| 2021-08-12 | 2021-06-30 | $-0.57 | $-0.70 |
| 2021-05-13 | 2021-03-31 | $-0.37 | $-0.54 |
| 2021-03-29 | 2020-12-31 | $-0.61 | $-1.37 |